SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Manipal Health Enterprises Ltd (MANIPALHOS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: MANIPALHOS Hospital & Healthcare Services | Small Cap | Manipal Health Enter Share Price

BSE Share Price
Not Listed

Manipal Health Enterprises Ltd (MANIPALHOS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: MANIPALHOS Hospital & Healthcare Services | Small Cap | Manipal Health Enter Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹1,299 Cr.
Book Value per Share
-
P/E Ratio
0.00
Industry PE
98.5
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
11.79%
Return on Capital Employed (ROCE)
13.02%
Return on Assets (ROA)
7.34%
Operating Profit Margin
27.2%
Net Profit Margin
17.24%
Gross Profit Margin
25.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
14.67%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
8.24%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
59.14%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹1,583 Cr.
Equity
₹0 Cr.
Face Value
-
All Time Low / High
- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 8.8%6.4%4.7%6.7%10.2%5.4%14.5%10.1%13.7%13%-

Growth Parameters

Sales 1,0931,2421,2971,4361,6721,4072,1202,4082,7073,1041,299
Sales YoY Gr.-13.6%4.4%10.7%16.4%-15.9%50.7%13.6%12.4%14.7%-
Adj EPS 0.70.10.10.21.20.42.42.63.423.10
YoY Gr.--81.8%16.7%35.7%515.8%-63.3%448.8%11.9%27.3%586.3%-
BVPS (₹) 1715.91616.317.217.127.829.634.4224.10
Adj Net
Profit
59.812.414.919.212043.9267299381533NAN
Cash Flow from Ops. 110231229321416390375616624644-
Debt/CF from Ops. 5.64.753.62.72.83.22.12.12.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 12.3%13.2%13.6%14.7%
Adj EPS 48.4%81.5%113.8%586.3%
BVPS33.2%67%100.4%552.2%
Share Price - - - -

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4.80.80.91.16.92.510.89.110.511.70
Op. Profit
Mgn %
16.417.117.92024.121.225.328.328.927.2NAN
Net Profit
Mgn %
5.511.11.37.23.112.612.414.117.2NAN
Debt to
Equity
0.40.70.70.70.60.60.40.40.30.4-
Working Cap
Days
13211812413913717013110175740
Cash Conv.
Cycle
-45-12-33-77-128-97-118-71-530

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1,093.451,242.221,297.201,436.271,672.181,406.762,119.562,408.192,706.953,104.10
Operating Expenses + 914.691,030.081,064.571,149.641,271.051,108.131,648.271,735.551,925.812,258.63
Manufacturing Costs55.89375.98372.62414.02121.8546.4578.7084.81682.92795.17
Material Costs260.97293.14299.80321.18357.76318.53563.74499.90531.86607.76
Employee Cost 176.80195.11203.44220.70254.03239.95305.54351.14415.59493.16
Other Costs 421.03165.85188.71193.74537.41503.20700.29799.70295.44362.54
Operating Profit 178.76212.14232.63286.63401.13298.63471.29672.64781.14845.47
Operating Profit Margin (%) 16.3%17.1%17.9%20.0%24.0%21.2%22.2%27.9%28.9%27.2%
Other Income + 65.8454.7040.9742.9250.9372.38116.9365.1194.49101.19
Exceptional Items -6.260-21.77-6.29-35.35-88.0458.65-141.88-63.200
Interest 66.03136.34135.69132.23157.29150.82185.40171.65168.41149.02
Depreciation 85.98110.83121132.95122.76128.16125.45139.35139.13148.99
Profit Before Tax 86.3319.67-4.8658.08136.663.99336.02284.87504.89648.65
Tax 30.87-14.13-21.1428.8942.3620.3872.3090.53168.53113.35
Profit After Tax 55.4633.8016.2829.1994.30-16.39263.72194.34336.36535.30
PAT Margin (%) 5.1%2.7%1.3%2.0%5.6%-1.2%12.4%8.1%12.4%17.2%
Adjusted EPS (₹)0.60.30.20.30.9-0.22.31.73.023.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Manipal Health Enter - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1,538.991,634.961,651.651,681.051,775.461,759.213,158.863,354.313,897.845,180.63
Share Capital 60.4968.6968.6968.6968.6968.6975.6375.6375.6377.06
Reserves 1,478.501,566.271,582.961,612.361,706.771,690.523,083.233,278.683,822.215,103.57
Debt +569.511,067.801,114.521,122.181,062.121,073.051,182.161,280.911,160.651,671.54
Long Term Debt532.511,041.041,112.471,122.181,062.12975.02870.371,144.121,160.651,671.54
Short Term Debt3726.762.050098.03311.79136.7900
Minority Interest0000000000
Trade Payables74.28107.85170.50238.28261.03358.16378.24456.63433.06412.04
Others Liabilities 245.74208.66228.80266.48649.61558.941,018.99537.15723.791,105.15
Total Liabilities 2,428.523,019.273,165.473,307.993,748.223,749.365,738.255,6296,215.348,369.36

Fixed Assets

Net Fixed Assets +1,308.431,675.891,664.621,634.201,949.081,572.851,541.441,543.701,588.911,652.28
Gross Block1,614.332,037.652,146.562,248.742,6792,353.132,419.182,523.992,670.482,832.68
Accumulated Depreciation305.90361.76481.94614.54729.92780.28877.74980.291,081.571,180.40
CWIP 48.6942.1837.0851.9684.60381.43388.47374.11377.511,305.84
Investments 645.83892.52953.76963.711,030.271,114.612,937.153,202.123,390.914,635.67
Inventories30.7832.7626.3426.0927.1513.8437.4516.0630.9527.65
Trade Receivables94.12106.71108.48117.8896.0484.85158.40127.64133.38190.74
Cash Equivalents 8.3519.8819.2554.0437.5215.5120.4728.61227.93149.57
Others Assets 292.32249.33355.94460.11523.56566.27654.87336.76465.75407.61
Total Assets 2,428.523,019.273,165.473,307.993,748.223,749.365,738.255,6296,215.348,369.36

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 110.25231.01228.65320.70415.58390.47375.49616623.69644.28
PBT 86.3319.67-4.8658.08136.663.99336.02284.87504.89648.65
Adjustment 47.03207.14240.15243.78269.69200.55196.67394.02298.83242.29
Changes in Working Capital -38.9211.5728.2360.8349.13114.48-103.1563.71-26.03-91.89
Tax Paid -47.19-7.37-34.87-41.99-39.9071.45-54.05-126.60-154-154.77
Cash Flow From Investing Activity + -180.92-381.50-165.44-177.87-252.45-212.81-1,465.32-511.21-405-1,851.58
Capex 201.03-211.1377.94352.64-131.03-74.10-67.11-139.53-142.93-703.56
Net Investments -131.34-106.17-140.56-391.680-10.68-65.65-278.70-146.04-198.43
Others -250.61-64.20-102.82-138.83-121.42-128.03-1,332.56-92.98-116.03-949.59
Cash Flow From Financing Activity + 57.03197.29-37.67-106.92-177.55-198.491,094.80-96.65-19.371,107.19
Net Proceeds from Shares 0000001,136.7800750
Net Proceeds from Borrowing 00000-56.210000
Interest Paid -60.87-126.77-124.69-118.81-30.44-106.56-128.71-31.56-144.16-136.49
Dividend Paid 0000000000
Others 117.90324.0687.0211.89-147.11-35.7286.73-65.09124.79493.68
Net Cash Flow -13.6446.8025.5435.91-14.42-20.834.978.14199.32-100.11

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)4.412.130.991.755.46-0.9310.725.979.2811.79
ROCE (%)8.796.394.746.7410.25.3814.4810.1313.6513.02
Asset Turnover Ratio0.560.460.420.440.470.380.450.420.460.43
PAT to CFO Conversion(x)1.996.8314.0410.994.41N/A1.423.171.851.2
Working Capital Days
Receivable Days24.8029.5030.3028.8023.4023.5020.9021.7017.6019.10
Inventory Days9.109.308.306.705.805.304.404.103.203.50
Payable Days85.60113.40169.40232.30254.70354.80238.40304.80305.30253.80

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Manipal Health Enterprises Ltd FAQs

The current trading price of Manipal Health Enter on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Manipal Health Enter stood at ₹0.00 Cr

The latest P/E ratio of Manipal Health Enter as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Manipal Health Enter as of 31-Dec-1969 is 0.00.

The 52-week high of Manipal Health Enter is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Manipal Health Enter is ₹1,299 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Manipal Health Enterprises Ltd

Manipal Health Enterprises was originally incorporated in Bengaluru, Karnataka as ‘Manipal Health Enterprises Private Limited’ as a private limited company on February 15, 2010. Subsequently, the company was converted to a public limited company, and the name of the company was changed to Manipal Health Enterprises Limited pursuant to resolutions passed by the Board and the Shareholders on November 8, 2025 and November 20, 2025, respectively.

The company operates a pan India network of multispecialty hospitals delivering a comprehensive range of care services - from outpatient services to complex tertiary and quaternary interventions. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO R). These specialties involve high acuity cases or cases that are severe, complex and require advanced interventions and high levels of care.

Business area of the company 

The company is engaged in the business of running/managing hospitals, and providing healthcare services. It operates through various Hospitals/clinics providing Healthcare services and diagnostic centres, primarily in India.

Services of the company

  • Cardiac sciences
  • Oncology
  • Neuro sciences
  • Gastro sciences
  • Orthopedics
  • Renal sciences
  • Total CONGO-R
  • Internal medicine
  • General surgery
  • Obstetrics and Gynecology
  • Pediatrics
  • Critical care
  • Pulmonology
  • Ears, nose and throat 

Awards, accreditations and recognition 

  • 2017: The company was awarded, ‘Company with Great Managers’ at the People Business - The Great Manager Awards by the Economic Times.
  • 2019: The company (along with Dr. H Sudarshan Ballal) entered the ‘Guinness World Records’ for the largest kidney disease awareness lesson delivered.
  • 2019: The company entered the ‘Guinness World Records’ for the most urinalysis tests done in 8 hours.
  • 2022: The company was awarded, ‘Best Hospital Chain - National’ at the Economic Times Healthcare Awards, 2022.
  • 2022: The company entered the ‘Guinness World Records’ for the most pledges received to learn cardiopulmonary resuscitation in 24 hours.
  • 2023: The company was awarded ‘Healthcare Company of the Year’ at the VCCircle Awards 2023.
  • 2024: The company entered the ‘Guinness World Records’ for the most people in a Cardiopulmonary Resuscitation (CPR) relay.
  • 2025: Manipal Hospital Whitefield, Bengaluru, Karnataka was awarded ‘Best Multi-speciality Hospitals - Emerging Hospitals’ at The Week Health Summit, 2025.
  • 2025: Manipal Hospital Bhubaneshwar, Orissa was awarded ‘Best Multi-speciality Hospital (Private)’ at The Week Health Summit, 2025.
  • 2025: Manipal Hospital Old Airport Road, has been rated the number one hospital in Bengaluru (Karnataka) for 20 years between 2005 to 2025 by The Week-Hansa Survey (except in 2017 where it was the second-best hospital).
  • 2026: MHPL, the subsidiary was awarded ‘Care Delivery (Hospitals/Diagnostics) Company of the Year’ at the VCCircle Awards 2026.
  • 2026: The company was awarded ‘Excellence in Healthcare Industry Leadership’ at the Healthcare Institutional Excellence Awards, 2026.
  • 2026: The company was awarded ‘Integrated Hospital/Clinic Network of the Year’ at The Economic Times Maharashtra Business Awards, 2026.

History and milestones

  • 1991: Manipal Hospital Old Airport Road, Bengaluru, Karnataka, commenced operations.
  • 1993: Expanded presence in Bengaluru through Manipal North Side Hospital, Bengaluru, Karnataka.
  • 1994 Expanded presence to Goa through Manipal Hospital Goa.
  • 1997: KMC Hospital, Mangalore (formerly known as Kasturba Medical College Hospital) commenced operations.
  • 2006: Manipal Hospital Vijayawada commenced operations.
  • 2007: Expanded presence in Tamil Nadu through Manipal Hospital, Salem.
  • 2008: Manipal Hospital Old Airport Road, Bengaluru, Karnataka received certificate of accreditation from National Association Board for Hospitals and Healthcare Providers.
  • 2008: Expanded presence in Bengaluru through Malathi Manipal Hospital, Bengaluru, Karnataka.
  • 2014: Expanded presence in Rajasthan through Manipal Hospital Jaipur, Rajasthan.
  • 2016: Manipal Hospital Whitefield, Bengaluru, Karnataka commenced operations.
  • 2018: HCMCT Manipal Hospital Dwarka, New Delhi commenced operations.
  • 2021: The company completed the acquisition of MHPL (formerly known as Columbia Asia Hospitals Private Limited).
  • 2021: The company completed the acquisition of MHBPL (formerly known as Vikram Hospital (Bengaluru) Private Limited).
  • 2022: Manipal Hospital Pune Baner commenced operations.
  • 2023: The company completed the acquisition of MHEIPL (formerly known as AMRI Hospitals Limited).
  • 2024: The company completed the acquisition of MHSPL (formerly known as Medica Synergie Private Limited).
  • 2025: The company acquired the Sahyadri Group by way of acquisition of majority shareholding of SHPL.
  • 2025: Manipal Hospital Kanakapura Road commenced operations.
  • 2025: Manipal Hospital Yelahanka commenced operations.

You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: